VBI Vaccines Initiates Restructuring Proceedings Under CCAA to ...
CAMBRIDGE, Mass., July 30, 2024 -- (BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful …
VBI Vaccines Announces Completion of Sales Process to K2
6 days ago · VBI Vaccines Inc. is a biopharmaceutical company which, through its innovative approach to virus-like particles ("VLPs"), including a proprietary enveloped VLP ("eVLP") …
VBI Vaccines Restructures and Acquired by K2 VBI Trust
6 days ago · VBI Vaccines Inc. is a biopharmaceutical company that develops vaccine candidates using innovative virus-like particles (VLP) technologies, including a proprietary enveloped VLP …
VBI Vaccines Inc. (VBIVQ) Latest Stock News & Headlines - Yahoo …
Get the latest VBI Vaccines Inc. (VBIVQ) stock news and headlines to help you in your trading and investing decisions.
VBI Vaccines Provides an Update on its Restructuring Proceedings …
CAMBRIDGE, Mass., Dec. 10, 2024 /PRNewswire/ - VBI Vaccines Inc. ("VBI" or the "Company") today provided an update on the restructuring proceedings announced on July 30, 2024. …
VBI Vaccines Announces Completion of Sales Process to K2 - PR …
6 days ago · VBI Vaccines Inc. is a biopharmaceutical company which, through its innovative approach to virus-like particles ("VLPs"), including a proprietary enveloped VLP ("eVLP") …
VBI Vaccines Provides an Update on its ... - Longview News-Journal
CAMBRIDGE, Mass., Dec. 10, 2024 /CNW/ - VBI Vaccines Inc. ("VBI" or the "Company") today provided an update on the restructuring proceedings announced on July 30, 2024.
Brii Biosciences acquires VBI Vaccines' drug assets for $18M
Jan 2, 2025 · Brii Biosciences acquires BRII-179 assets from VBI Vaccines. The $18 million deal cancels previous agreements and obligations. BRII-179 is in Phase 2 study as a hepatitis B …
VBI recalls PreHevbrio and winds down operations
Nov 19, 2024 · Massachusetts, USA-based firm VBI Vaccines (Nasdaq: VBIV) has initiated a nationwide voluntary recall of PreHevbrio (hepatitis B vaccine), as it proceeds with bankruptcy …
VBI Vaccines provides restructuring proceedings update - MSN
VBI Vaccines (NASDAQ: VBIV) on Friday said that on August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the …